Results 201 to 210 of about 88,249 (251)

Nanobodies as next‐generation targeting platforms: From discovery technologies to translational biomedicine

VIEW, EarlyView.
Nanobodies, derived from the variable domains of camelid heavy‐chain‐only antibodies, have emerged as transformative biomedical tools due to their nanoscale size, exceptional stability, and unique capacity to recognize cryptic epitopes. This review provides a comprehensive overview of the field, outlining the structural and biochemical features of ...
Zhenrui Ye, Xianyang Li, Meixiao Zhan
wiley   +1 more source

Nanomedicine applications in lymphoma: Advancing precision diagnostics, targeted therapeutics, and prospective developments

VIEW, EarlyView.
Lymphoma is a group of blood cancers that can appear in lymph nodes, blood, bone marrow, spleen, liver, or the central nervous system, which makes drug delivery and disease monitoring difficult. This review summarizes how nanomedicine technologies may improve targeted treatment and imaging, while carefully separating approved or guideline‐supported ...
Mohd Ahmar Rauf, Yara Mashal, Afeefa Rao, Nasar Ata, Arun K. Iyer, Farhan Shah   +5 more
wiley   +1 more source

Comparative Quality Assessment of Artificial Intelligence in Patient Education on Platelet-Rich Plasma (PRP) Therapy. [PDF]

J Pers Med
Krueckel J, Szymski D, Ahmad N, Schiffelholz D, Weber J, Buchhorn S, Buchhorn T, Fehske K, Lang S, Alt V, Hilber F.   +10 more
europepmc   +1 more source

Comparison of ultrasound-guided dry needling and platelet-rich plasma injection in the management of refractory lateral epicondyle tendinopathy. [PDF]

Clin Shoulder Elb
Terzi MM, Kıratlıoğlu Y, Bezirgan U, Armangil M.   +3 more
europepmc   +1 more source

Best evidence summary for platelet-rich plasma treatment of chronic wounds. [PDF]

Regen Ther
Zhang X, Zhang X, Wang L, Zhen L, Lin M, Li Y, Gong L, Zeng H, Ruan W, Zhu M.   +9 more
europepmc   +1 more source

Platelet-rich plasma enhances post-conditioning recovery from testicular ischemia-reperfusion injury: a novel experimental approach. [PDF]

Sci Rep
Amena-Elmongy, Gannah-Samy, Samy A, Shouman Z, Megahed A, Karrouf G.   +5 more
europepmc   +1 more source

Effects of autologous platelet-rich plasma in recurrent implantation failure: a systematic review and meta-analysis. [PDF]

Front Endocrinol (Lausanne)
Pan Z, Guo X, Su Q, Ye H.
europepmc   +1 more source

Platelet-rich plasma and hyaluronic acid in the treatment of acute ankle sprains: A review. [PDF]

Biomol Biomed
Chen YT, Wu WT, Lee RP, Yu TC, Chen IH, Yeh KT.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Platelet-Rich Plasma

Physical Medicine and Rehabilitation Clinics of North America, 2016
Platelet-rich plasma (PRP) is a growing and robust therapeutic option in musculoskeletal medicine. PRP is a preparation of autologous plasma enriched with a platelet concentration above that normally contained in whole blood. The rationale for use and therapeutic potential of a high concentration of platelets is based on their capacity to supply ...
Peter I-Kung, Wu, Robert, Diaz, Joanne, Borg-Stein   +2 more
  +6 more sources